Centessa Pharmaceuticals CEO Saurabh Saha Sells 55,000 Shares

TradingView
2025.04.22 21:50
portai
I'm PortAI, I can summarize articles.

Centessa Pharmaceuticals CEO Saurabh Saha sold 55,000 shares on April 21 and 22, 2025, totaling $681,576. The sales occurred at average prices of $12.2885 and $12.43. Post-sale, Saha holds 221,017 shares directly and 38,000 shares indirectly through a trust. The transactions were made under a Rule 10b5-1 trading plan established on May 16, 2024.

Reporter NameSaha Saurabh
RelationshipChief Executive Officer
TypeSell
Amount$681,576
SEC FilingForm 4

Centessa Pharmaceuticals plc's CEO, Saurabh Saha, sold a total of 55,000 ordinary shares on April 21 and April 22, 2025, for a total sale amount of $681,576. The sales were made at weighted average prices of $12.2885 and $12.43 respectively, indicating multiple transactions at varying prices. Following these transactions, Saha directly owns 221,017 ordinary shares and indirectly owns 38,000 shares through a trust. The sales were executed under a Rule 10b5-1 trading plan adopted on May 16, 2024.

SEC Filing: Centessa Pharmaceuticals plc [ CNTA ] - Form 4 - Apr. 22, 2025

Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.